Vozarova de Courten Barbora, Weyer Christian, Stefan Norbert, Horton Mark, DelParigi Angelo, Havel Peter, Bogardus Clifton, Tataranni P Antonio
Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, USA.
Diabetes. 2004 Mar;53(3):663-71. doi: 10.2337/diabetes.53.3.663.
There is evidence from animal models of obesity and type 2 diabetes that increased parasympathetic vagal input to the pancreas contributes to hyperinsulinemia. Compared with Caucasians, Pima Indians have a high risk of type 2 diabetes and exhibit marked hyperinsulinemia and elevated plasma levels of pancreatic polypeptide (PP), an islet hormone considered a surrogate marker of parasympathetic nervous system (PNS) drive to the pancreas. To test if hyperinsulinemia in Pima Indians is due to increased vagal input to the beta-cell, we examined the effect of PNS blockade in 17 Caucasian (aged 35 +/- 8 years, body fat 23 +/- 7% [mean +/- SD]) and 17 Pima Indian males (aged 28 +/- 8 years, body fat 29 +/- 5%) with normal glucose tolerance. Each participant underwent four consecutive standardized liquid meal tests (64% carbohydrate, 22% fat, and 14% protein) during which a primed infusion of atropine was administered for 120 min at the following doses: 0, 2.5, 5, and 10 micro g. kg fat-free mass (FFM)(-1). h(-1). Areas under the curve for early (AUC(0-30 min)) and total (AUC(0-120 min)) postprandial insulin and PP secretory responses were calculated. Early postprandial insulin and PP secretory responses were higher in Pima Indians compared with those of Caucasians (both P = 0.01). Secretion of insulin and PP was inhibited by atropine (both P < 0.001). Increasing doses of atropine attenuated the ethnic difference in PP (P = 0.01) but not in early insulin secretory responses (P = 0.6), an effect that was not due to differences in gastric emptying rate (acetaminophen test) and/or circulating glucose. Similar results were observed for total secretory responses. These results confirm that compared with Caucasians, Pima Indians have an exaggerated PNS drive to pancreatic F-cells that secrete PP. However, the hyperinsulinemia of this population does not appear to be due to increased vagal input to pancreatic beta-cells.
肥胖和2型糖尿病动物模型的证据表明,胰腺副交感神经迷走神经输入增加会导致高胰岛素血症。与高加索人相比,皮马印第安人患2型糖尿病的风险较高,表现出明显的高胰岛素血症和血浆胰多肽(PP)水平升高,胰多肽是一种胰岛激素,被认为是副交感神经系统(PNS)对胰腺驱动的替代标志物。为了测试皮马印第安人的高胰岛素血症是否由于迷走神经对β细胞的输入增加,我们研究了17名糖耐量正常的高加索男性(年龄35±8岁,体脂23±7%[平均值±标准差])和17名皮马印第安男性(年龄28±8岁,体脂29±5%)中PNS阻断的效果。每位参与者连续进行四次标准化液体餐试验(64%碳水化合物、22%脂肪和14%蛋白质),在此期间,以以下剂量静脉注射阿托品120分钟:0、2.5、5和10μg·kg去脂体重(FFM)-1·h-1。计算餐后早期(AUC(0-30分钟))和总(AUC(0-120分钟))胰岛素和PP分泌反应的曲线下面积。与高加索人相比,皮马印第安人餐后早期胰岛素和PP分泌反应更高(P均=0.01)。阿托品抑制胰岛素和PP的分泌(P均<0.001)。阿托品剂量增加减弱了PP的种族差异(P=0.01),但未减弱早期胰岛素分泌反应(P=0.6),这种效应不是由于胃排空率(对乙酰氨基酚试验)和/或循环葡萄糖的差异所致。总分泌反应也观察到类似结果。这些结果证实,与高加索人相比,皮马印第安人对分泌PP的胰腺F细胞的PNS驱动更为强烈。然而,该人群的高胰岛素血症似乎并非由于迷走神经对胰腺β细胞的输入增加所致。